These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 32656801)
21. Combinational Effects of Active Targeting, Shape, and Enhanced Permeability and Retention for Cancer Theranostic Nanocarriers. Tahmasbi Rad A; Chen CW; Aresh W; Xia Y; Lai PS; Nieh MP ACS Appl Mater Interfaces; 2019 Mar; 11(11):10505-10519. PubMed ID: 30793580 [TBL] [Abstract][Full Text] [Related]
22. Facile development of biodegradable polymer-based nanotheranostics: Hydrophobic photosensitizers delivery, fluorescence imaging and photodynamic therapy. Thakur NS; Patel G; Kushwah V; Jain S; Banerjee UC J Photochem Photobiol B; 2019 Apr; 193():39-50. PubMed ID: 30818153 [TBL] [Abstract][Full Text] [Related]
23. Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy. Ding Z; Liu P; Hu D; Sheng Z; Yi H; Gao G; Wu Y; Zhang P; Ling S; Cai L Biomater Sci; 2017 Mar; 5(4):762-771. PubMed ID: 28256661 [TBL] [Abstract][Full Text] [Related]
24. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine. Du JZ; Li HJ; Wang J Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728 [TBL] [Abstract][Full Text] [Related]
25. A Tumor Microenvironment Destroyer for Efficient Cancer Suppression. Yao H; Xu K; Zhou J; Zhou L; Wei S ACS Biomater Sci Eng; 2020 Jan; 6(1):450-462. PubMed ID: 33463237 [TBL] [Abstract][Full Text] [Related]
26. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer. Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139 [TBL] [Abstract][Full Text] [Related]
27. A nanoplatform with tumor-targeted aggregation and drug-specific release characteristics for photodynamic/photothermal combined antitumor therapy under near-infrared laser irradiation. Xie M; Zhu Y; Xu S; Xu G; Xiong R; Sun X; Liu C Nanoscale; 2020 Jun; 12(21):11497-11509. PubMed ID: 32427255 [TBL] [Abstract][Full Text] [Related]
28. From Dyestuff Chemistry to Cancer Theranostics: The Rise of Rylenecarboximides. Ji C; Cheng W; Yuan Q; Müllen K; Yin M Acc Chem Res; 2019 Aug; 52(8):2266-2277. PubMed ID: 31373482 [TBL] [Abstract][Full Text] [Related]
29. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Shi J; Xiao Z; Kamaly N; Farokhzad OC Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448 [TBL] [Abstract][Full Text] [Related]
30. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery. Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767 [TBL] [Abstract][Full Text] [Related]
31. A switchable NO-releasing nanomedicine for enhanced cancer therapy and inhibition of metastasis. Xu Y; Ren H; Liu J; Wang Y; Meng Z; He Z; Miao W; Chen G; Li X Nanoscale; 2019 Mar; 11(12):5474-5488. PubMed ID: 30855625 [TBL] [Abstract][Full Text] [Related]
32. Rational design of multimodal therapeutic nanosystems for effective inhibition of tumor growth and metastasis. Wang F; Huang Q; Wang Y; Zhang W; Lin R; Yu Y; Shen Y; Cui H; Guo S Acta Biomater; 2018 Sep; 77():240-254. PubMed ID: 30012354 [TBL] [Abstract][Full Text] [Related]
33. Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy. Ma J; Wu H; Li Y; Liu Z; Liu G; Guo Y; Hou Z; Zhao Q; Chen D; Zhu X Pharm Res; 2018 Feb; 35(3):57. PubMed ID: 29423532 [TBL] [Abstract][Full Text] [Related]
34. Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release. Qiao H; Cui Z; Yang S; Ji D; Wang Y; Yang Y; Han X; Fan Q; Qin A; Wang T; He XP; Bu W; Tang T ACS Nano; 2017 Jul; 11(7):7259-7273. PubMed ID: 28692257 [TBL] [Abstract][Full Text] [Related]
35. A Small Molecule Nanodrug by Self-Assembly of Dual Anticancer Drugs and Photosensitizer for Synergistic near-Infrared Cancer Theranostics. Guo Y; Jiang K; Shen Z; Zheng G; Fan L; Zhao R; Shao J ACS Appl Mater Interfaces; 2017 Dec; 9(50):43508-43519. PubMed ID: 29171263 [TBL] [Abstract][Full Text] [Related]
36. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor. Yang X; Shi X; Ji J; Zhai G Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333 [TBL] [Abstract][Full Text] [Related]
37. Neutrophils as an emerging therapeutic target and tool for cancer therapy. Subhan MA; Torchilin VP Life Sci; 2021 Nov; 285():119952. PubMed ID: 34520766 [TBL] [Abstract][Full Text] [Related]
38. Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo. Zhang J; Liang YC; Lin X; Zhu X; Yan L; Li S; Yang X; Zhu G; Rogach AL; Yu PK; Shi P; Tu LC; Chang CC; Zhang X; Chen X; Zhang W; Lee CS ACS Nano; 2015 Oct; 9(10):9741-56. PubMed ID: 26390118 [TBL] [Abstract][Full Text] [Related]
39. A Cell Membrane-Targeting Self-Delivery Chimeric Peptide for Enhanced Photodynamic Therapy and In Situ Therapeutic Feedback. Ma W; Sha SN; Chen PL; Yu M; Chen JJ; Huang CB; Yu B; Liu Y; Liu LH; Yu ZQ Adv Healthc Mater; 2020 Jan; 9(1):e1901100. PubMed ID: 31763796 [TBL] [Abstract][Full Text] [Related]
40. Tumor Targeting Strategies of Smart Fluorescent Nanoparticles and Their Applications in Cancer Diagnosis and Treatment. He J; Li C; Ding L; Huang Y; Yin X; Zhang J; Zhang J; Yao C; Liang M; Pirraco RP; Chen J; Lu Q; Baldridge R; Zhang Y; Wu M; Reis RL; Wang Y Adv Mater; 2019 Oct; 31(40):e1902409. PubMed ID: 31369176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]